Pharma Journalist -

SMi Reports: A panel discussion has been set for the 12th annual Pre-Filled Syringes and Injectable Drug Devices conference to be held in London on the 15th and 16th January.  The 12th…
Read More...

UCB and Ra Pharmaceuticals Inc. announced their entry into a merger agreement pursuant for which UCB will acquire Ra Pharma. Under the terms of the agreement, Ra Pharma shareholders…
Read More...

Biocatalysis multinationals such as GlaxoSmithKline plc, AstraZeneca, Givaudan, Roche, Firmenich, and L’Oréal will present at the conference alongside academic innovators, including,…
Read More...

Dermira, Inc. announced that detailed primary results of its Phase 2b study of lebrikizumab in patients with moderate-to-severe atopic dermatitis will be reported at the 39th Annual…
Read More...

Alexion Pharmaceuticals and Stealth BioTherapeutics Corp announced an agreement for an option to co-develop and commercialize elamipretide for mitochondrial diseases. Currently being…
Read More...

Avacta Group plc announces that it has entered a collaboration and option agreement with ADC Therapeutics SA (Lausanne, CH), a clinical-stage oncology-focused biotechnology company…
Read More...

Clinigen Group plc has launched a Managed Access Program for Progenics Pharmaceuticals, Inc., an oncology company developing innovative targeted medicines and artificial intelligence to…
Read More...

VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived…
Read More...

Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated, announced it has entered into a global licensing agreement with Janssen Pharmaceutica NV and…
Read More...

Advaxis, Inc. announced a research collaboration agreement with the University of California Los Angeles (UCLA) to conduct preclinical studies evaluating the Company’s Lm technology in…
Read More...